Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.


Project Scope

Impact assessment of the estimands framework and recommendations/best practices (where applicable) for implementing the framework in the following areas:

  • Data Collect Design/CDASH
  • SDTM
  • ADaM (including handling of intercurrent events, missing data imputation) – Analysis Displays
  • cSDRG and ADRG

Development of new standards is not in scope, and any impact findings that may necessitate new standard development will be shared with CDISC for their consideration. Examples may be created on how to implement the framework by using permitted extensions to the existing data standards.



Project LeadsEmail
Chris Price

chris.price.cp1@roche.com

Lori VanMeterlvanmet@ITS.JNJ.com
Katie Warren (PHUSE Project Assistant)

katie@phuse.global.


Objectives & DeliverablesTimelines

Kick off

Feb 2022Q12022

Review current company practices 

March 2022Q12022

Develop conference abstract 

April 2022Q22022

Draft paper 

August 2022Q32022

Conference slides 

Oct 2022Q42022

Final paper for public review

Nov 2022Q42022

Final paper published

Jan 2023Q12023


Status
colourBlue
titleCURRENT STATUS

Project approved Feb 2022Q12022



Project MembersOrganisation
Rama EmpatiAstraZeneca
Bess Leroy CDISC
Lisa LinFDA
John Scott FDA
Liping Sun FDA
Steve Wilson FDA
Kim MusgraveAmgen
Cedric DavisterMerck 

Robin White

Eli Lilly and Company

Yongming Qu

Eli Lilly and Company
Santosh K LingalaGilead